EMEA Procedure number  
Invented name 
Strength  Pharmaceutical Form 
EMEA/H/C/734/001 
Mycamine 
50 mg 
EMEA/H/C/734/002 
Mycamine 
100 mg 
Powder for concentrate for 
solution for infusion 
Powder for concentrate for 
solution for infusion 
Route of 
administration 
Intravenous use 
Packaging 
Vial (glass) 
Content 
(concentration) 
10 ml 
Intravenous use 
Vial (glass) 
10 ml 
Package size
1 vial 
1 vial 
1 
